Bottom line
FHLC vs FACDX: the short answer
FHLC (Fidelity MSCI Health Care Index ETF) and FACDX (Fidelity Advisor Health Care Fund) share a meaningful slice of their top holdings — about 46% by weight.
But FHLC is far broader, holding 337 positions to 154 for FACDX, so beyond the top names it adds exposure FACDX doesn't have.
FHLC is cheaper at 0.084% vs 0.96% — a difference of $88 a year per $10,000 invested.
Over five years, FHLC returned +7.2% a year vs +2.3% for FACDX (reporting dates differ).
Updated Nov 19, 2026
FHLC vs FACDX side by side
| FHLC | FACDX | |
|---|---|---|
| Type | ETF | Mutual fund |
| Fund family | Fidelity | Fidelity |
| Category | Health Care Sector | Health Care Sector |
| Expense ratio | 0.084% | 0.96% |
| Annual cost per $10k | $8.4 | $96 |
| 10-yr cost on $10k (prospectus) | $108 | $1,685 |
| Max front load | None | — |
| 12b-1 fee | 0% | 0.25% |
| 1-yr return | +2.6% | +7.7% |
| 5-yr return (annualized) | +7.2% | +2.3% |
| 10-yr return (annualized) | +8.8% | +7.6% |
| Best quarter | +16.4% | +21.3% |
| Worst quarter | −13.1% | −15.0% |
| Net assets (fund) | $3.3B | $3.1B |
| Number of holdings | 337 | 154 |
| Portfolio turnover | 3% | 74% |
| Returns as of | Nov 30, 2025 | Sep 30, 2026 |
Source: SEC Form N-PORT and fund prospectuses
Year-by-year returns
| Year | FHLC | FACDX | Difference |
|---|---|---|---|
| 2024 | +2.6% | +3.9% | −1.3% |
| 2023 | +2.5% | +3.8% | −1.3% |
| 2022 | −5.5% | −13.1% | +7.6% |
| 2021 | +20.4% | +11.2% | +9.2% |
| 2020 | +18.1% | +21.1% | −2.9% |
| 2019 | +21.9% | +27.9% | −5.9% |
| 2018 | +5.5% | +7.3% | −1.8% |
| 2017 | +23.3% | +24.1% | −0.8% |
| 2016 | −3.3% | −10.3% | +7.0% |
| 2015 | +7.0% | +5.9% | +1.1% |
Source: Fund prospectus bar charts
Holdings overlap
10 of FHLC's top 25 holdings also appear in FACDX's top 25.
| Holding | FHLC | FACDX |
|---|---|---|
| Eli Lilly & Co | 13.35% | 7.66% |
| Johnson & Johnson | 8.93% | 3.78% |
| AbbVie Inc | 6.42% | 3.62% |
| UnitedHealth Group Inc | 5.44% | 4.17% |
| Merck & Co Inc | 4.66% | 2.09% |
| Thermo Fisher Scientific Inc | 3.09% | 6.31% |
| Gilead Sciences Inc | 2.34% | 1.25% |
| CVS Health Corp | 1.92% | 1.29% |
| Danaher Corp | 1.80% | 6.75% |
| Boston Scientific Corp | 1.00% | 1.23% |
Source: SEC Form N-PORT
FHLC top 10
- Eli Lilly & Co — 13.35%
- Johnson & Johnson — 8.93%
- AbbVie Inc — 6.42%
- UnitedHealth Group Inc — 5.44%
- Merck & Co Inc — 4.66%
- Thermo Fisher Scientific Inc — 3.09%
- Amgen Inc — 3.00%
- Abbott Laboratories — 2.66%
- Gilead Sciences Inc — 2.34%
- Pfizer Inc — 2.06%
FACDX top 10
- ELI LILLY and CO — 7.66%
- Danaher Corp — 6.75%
- Thermo Fisher Scientific Inc — 6.31%
- Unitedhealth Group Inc — 4.17%
- JOHNSON and JOHNSON — 3.78%
- Abbvie Inc — 3.62%
- Fidelity Revere Street Trust — 2.54%
- Argenx Se — 2.09%
- MERCK and CO INC — 2.09%
- West Pharmaceutical Svcs Inc — 2.06%
FAQ
What is the difference between FHLC and FACDX?
Which is cheaper, FHLC or FACDX?
Should I own both FHLC and FACDX?
Educational comparison based on public filings; not investment advice. Past performance does not guarantee future results.